BF.B
33
2
ORCL
65
-2
WAT
55
2
LYB
39
2
GIS
31
3
NWS
66
-3
FSLR
54
7
EL
25
4
YUM
47
3
AA
48
-12
NRG
49
-3
BBY
46
10
ES
34
3
FLR
58
3
HRB
57
5
PAYX
53
2
DVN
21
3
ILMN
42
5
XRX
44
3
VRSN
53
-4
BF.B
33
2
ORCL
65
-2
WAT
55
2
LYB
39
2
GIS
31
3
NWS
66
-3
FSLR
54
7
EL
25
4
YUM
47
3
AA
48
-12
NRG
49
-3
BBY
46
10
ES
34
3
FLR
58
3
HRB
57
5
PAYX
53
2
DVN
21
3
ILMN
42
5
XRX
44
3
VRSN
53
-4
Financhill
Back

Applied Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74

APLT
Applied Therapeutics

Last Price:
9.63
Seasonality Move:
58.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Applied Therapeutics Price Quote

$9.63
+0.01 (+3.88%)
(Updated: November 23, 2024 at 5:25 AM ET)

Applied Therapeutics Key Stats

Buy
74
Applied Therapeutics (APLT) is a Buy
Day range:
$8.95 - $9.64
52-week range:
$1.79 - $10.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
190.08%
Volume:
1.7M
Avg. volume:
1.7M
1-year change:
406.58%
Market cap:
$1.1B
Revenue:
$10M
EPS:
$-1.61

How Much Does Applied Therapeutics Make?

Is Applied Therapeutics Growing As A Company?

Data Unavailable

Applied Therapeutics Stock Price Performance

What Is Applied Therapeutics 52-Week High & Low?

Applied Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Applied Therapeutics?

Is Applied Therapeutics Cash Flow Positive?

  • What Is APLT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$81.8M
  • What Is Applied Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $143.3M
  • What Is Applied Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Applied Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    APLT return on invested capital is -790.52%
  • What Is Applied Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -192.86%
  • What Is APLT Return On Equity?
    ROE is a measure of profitability and is -797.82%

Applied Therapeutics Earnings Date & Stock Price

Applied Therapeutics Competitors

Applied Therapeutics Dividend Yield

Applied Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -195.49%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.67
Upside from Last Price: 52.38%

Major Shareholders

  • How many APLT shares are owned by institutional investors?
    162.1M APLT shares are owned by institutional investors
  • How many APLT shares are owned by insiders?
    8.3M APLT shares are owned by insiders